Valuation: VolitionRx Limited

Market Cap 5.98M 5.2M 4.85M 4.46M 8.4M 570M 8.55M 57.23M 22.42M 284M 22.47M 21.97M 938M P/E 2026 *
-0.32x
P/E 2027 * -0.52x
Enterprise Value 5.98M 5.2M 4.85M 4.46M 8.4M 570M 8.55M 57.23M 22.42M 284M 22.47M 21.97M 938M EV / Sales 2026 *
2.41x
EV / Sales 2027 * 1.04x
Free-Float
91.38%
Yield 2026 *
-
Yield 2027 * -
1 day+7.92%
1 week-12.83%
Current month+6.82%
1 month-43.18%
3 months-67.90%
6 months-85.91%
Current year-84.99%
1 week 0.69
Extreme 0.6901
0.97
1 month 0.69
Extreme 0.6901
1.53
Current year 0.69
Extreme 0.6901
7.73
1 year 0.69
Extreme 0.6901
15.1
3 years 0.69
Extreme 0.6901
27.6
5 years 0.69
Extreme 0.6901
82.8
10 years 0.69
Extreme 0.6901
136.8
Manager TitleAgeSince
Chief Executive Officer 55 06/10/2011
Director of Finance/CFO 56 01/02/2021
Chief Tech/Sci/R&D Officer 49 01/04/2024
Director TitleAgeSince
Director/Board Member 55 06/10/2011
Director/Board Member 77 06/10/2011
Director/Board Member 64 09/10/2019
Date Insider Type Main position Quantity % Market Cap.
17/3/26 Tax

Company Secretary

3,948 0.0029%
17/3/26 Tax

Chief Technology Officer

5,310 0.0039%
1/3/26
Concord International, Inc.
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+9.32%-12.83%-93.84%-97.05% 5.98M
-2.44%-17.49%+88.67%+80.08% 3.72B
+3.52%+3.77%+114.39%+235.58% 3.59B
+8.73%+33.91%+286.43%+353.77% 2.26B
-0.42%+4.11%-27.65%-35.55% 2.17B
+6.02%-13.27%+50.18%-41.22% 1.82B
-2.66%-3.06%+185.68%-46.23% 969M
-0.74%-2.55%-8.09%+20.27% 853M
+1.46%+7.96%-37.98%-10.07% 511M
+2.80%-0.52%+2.52% - 449M
Average +3.12%-3.91%+56.03%+51.07% 1.63B
Weighted average by Cap. +2.93%-3.02%+96.27%+110.61%

Financials

2026 *2027 *
Net sales 2.48M 2.15M 2.01M 1.85M 3.48M 236M 3.54M 23.7M 9.28M 118M 9.31M 9.1M 388M 5.73M 4.98M 4.65M 4.27M 8.05M 546M 8.19M 54.85M 21.48M 273M 21.54M 21.06M 899M
Net income -22.2M -19.3M -18.02M -16.54M -31.18M -2.12B -31.73M -212M -83.2M -1.06B -83.4M -81.55M -3.48B -19.62M -17.05M -15.92M -14.61M -27.56M -1.87B -28.04M -188M -73.51M -933M -73.69M -72.06M -3.08B
Net Debt - -
Logo VolitionRx Limited
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Employees
-
Date Price Change Volume
04/08/26 USD 0.8050 +12.09% 112,133
31/07/26 USD 0.7181 -10.20% 252,637
30/07/26 USD 0.7997 +3.51% 1,006,754
29/07/26 USD 0.7726 -9.24% 249,672
28/07/26 USD 0.8513 -3.26% 397,739
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.7181USD
Average target price
16.97USD
Spread / Average Target
+2,262.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VNRX Stock